Erlotinib in patients with advanced non-small-cell lung...

Medical Oncology 2012 / 03 Vol. 29; Iss. 1

Erlotinib in patients with advanced non-small-cell lung cancer: impact of dose reductions and a novel surrogate marker

Daniel Binder, Ann-Christin Buckendahl, Ralf-Harto Hübner, Peter Schlattmann, Bettina Temmesfeld-Wollbrück, Thomas Beinert, Norbert Suttorp
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Pages:
6
DOI:
10.1007/s12032-010-9767-x
Date:
March, 2012
File:
PDF, 234 KB
english, 2012
Conversion to is in progress
Conversion to is failed